Use of Gamma-interferon assays in low- and medium-prevalence countries in Europe: a consensus statement of a Wolfheze Workshop organised by KNCV/EuroTB, Vilnius Sept 2006

F Drobniewski; F Cobelens; J- P Zellweger; on behalf of the KNCV/EuroTB Workshop

doi:10.2807/esw.12.30.03242-en

Articles Open Access

Like 0

This item has no PDF Download

Use of Gamma-interferon assays in low- and medium-prevalence countries in Europe: a consensus statement of a Wolfheze Workshop organised by KNCV/EuroTB, Vilnius Sept 2006
F Drobniewski , F Cobelens , J- P Zellweger , on behalf of the KNCV/EuroTB Workshop
View Citation Hide Citation

Citation style for this article: Drobniewski F , Cobelens F , Zellweger J- P , on behalf of the KNCV/EuroTB Workshop . Use of Gamma-interferon assays in low- and medium-prevalence countries in Europe: a consensus statement of a Wolfheze Workshop organised by KNCV/EuroTB, Vilnius Sept 2006. Euro Surveill. 2007;12(30):pii=3242. https://doi.org/10.2807/esw.12.30.03242-en

Abstract

Interferon gamma release assays (IGRA) offer an alternative to tuberculin skin testing (TST or Mantoux) for the diagnosis of tuberculosis (TB) latent infection (LTBI) or as an additional diagnostic method for active TB.